164 related articles for article (PubMed ID: 36470859)
21. MiT family translocation renal cell carcinomas: A 15th anniversary update.
Gandhi JS; Malik F; Amin MB; Argani P; Bahrami A
Histol Histopathol; 2020 Feb; 35(2):125-136. PubMed ID: 31489603
[TBL] [Abstract][Full Text] [Related]
22. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Clark DJ; Dhanasekaran SM; Petralia F; Pan J; Song X; Hu Y; da Veiga Leprevost F; Reva B; Lih TM; Chang HY; Ma W; Huang C; Ricketts CJ; Chen L; Krek A; Li Y; Rykunov D; Li QK; Chen LS; Ozbek U; Vasaikar S; Wu Y; Yoo S; Chowdhury S; Wyczalkowski MA; Ji J; Schnaubelt M; Kong A; Sethuraman S; Avtonomov DM; Ao M; Colaprico A; Cao S; Cho KC; Kalayci S; Ma S; Liu W; Ruggles K; Calinawan A; Gümüş ZH; Geiszler D; Kawaler E; Teo GC; Wen B; Zhang Y; Keegan S; Li K; Chen F; Edwards N; Pierorazio PM; Chen XS; Pavlovich CP; Hakimi AA; Brominski G; Hsieh JJ; Antczak A; Omelchenko T; Lubinski J; Wiznerowicz M; Linehan WM; Kinsinger CR; Thiagarajan M; Boja ES; Mesri M; Hiltke T; Robles AI; Rodriguez H; Qian J; Fenyö D; Zhang B; Ding L; Schadt E; Chinnaiyan AM; Zhang Z; Omenn GS; Cieslik M; Chan DW; Nesvizhskii AI; Wang P; Zhang H;
Cell; 2019 Oct; 179(4):964-983.e31. PubMed ID: 31675502
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas.
Medendorp K; van Groningen JJ; Schepens M; Vreede L; Thijssen J; Schoenmakers EF; van den Hurk WH; Geurts van Kessel A; Kuiper RP
Cytogenet Genome Res; 2007; 118(2-4):157-65. PubMed ID: 18000366
[TBL] [Abstract][Full Text] [Related]
24. NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma.
Chen Y; Yang L; Liu N; Shi Q; Yin X; Han X; Gan W; Li D
Curr Cancer Drug Targets; 2021; 21(8):713-723. PubMed ID: 33845743
[TBL] [Abstract][Full Text] [Related]
25. A review of neoplasms with MITF/MiT family translocations.
Wei S; Testa JR; Argani P
Histol Histopathol; 2022 Apr; 37(4):311-321. PubMed ID: 35107169
[TBL] [Abstract][Full Text] [Related]
26. Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.
Sun G; Chen J; Liang J; Yin X; Zhang M; Yao J; He N; Armstrong CM; Zheng L; Zhang X; Zhu S; Sun X; Yang X; Zhao W; Liao B; Pan X; Nie L; Yang L; Chen Y; Zhao J; Zhang H; Dai J; Shen Y; Liu J; Huang R; Liu J; Wang Z; Ni Y; Wei Q; Li X; Zhou Q; Huang H; Liu Z; Shen P; Chen N; Zeng H
Nat Commun; 2021 Sep; 12(1):5262. PubMed ID: 34489456
[TBL] [Abstract][Full Text] [Related]
27. PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.
Wang B; Yin X; Gan W; Pan F; Li S; Xiang Z; Han X; Li D
Autophagy; 2021 Sep; 17(9):2475-2493. PubMed ID: 33019842
[TBL] [Abstract][Full Text] [Related]
28. Autophagy in Xp11 translocation renal cell carcinoma: from bench to bedside.
Sun H; Wei X; Zeng C
Mol Cell Biochem; 2021 Dec; 476(12):4231-4244. PubMed ID: 34345999
[TBL] [Abstract][Full Text] [Related]
29. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; Pivovarčikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
[TBL] [Abstract][Full Text] [Related]
30. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Classe M; Malouf GG; Su X; Yao H; Thompson EJ; Doss DJ; Grégoire V; Lenobin J; Fantoni JC; Sudour-Bonnange H; Khayat D; Aubert S; Tannir NM; Leroy X
Histopathology; 2017 Jun; 70(7):1089-1097. PubMed ID: 28106924
[TBL] [Abstract][Full Text] [Related]
31. Cyto-histological correlation of Xp11.2 translocation/TFE3 gene fusion associated renal cell carcinoma: Report of a case with review of literature.
Manucha V; Sessums MT; Lewin J; Akhtar I
Diagn Cytopathol; 2018 Mar; 46(3):267-270. PubMed ID: 29024535
[TBL] [Abstract][Full Text] [Related]
32. Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
Caliò A; Brunelli M; Gobbo S; Pedron S; Segala D; Argani P; Martignoni G
Pathology; 2021 Aug; 53(5):579-585. PubMed ID: 33461798
[TBL] [Abstract][Full Text] [Related]
33. Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary Modalities.
Tretiakova MS
Adv Anat Pathol; 2022 May; 29(3):131-140. PubMed ID: 35180736
[TBL] [Abstract][Full Text] [Related]
34. Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.
Wyvekens N; Rechsteiner M; Fritz C; Wagner U; Tchinda J; Wenzel C; Kuithan F; Horn LC; Moch H
Virchows Arch; 2019 May; 474(5):625-631. PubMed ID: 30706129
[TBL] [Abstract][Full Text] [Related]
35. PRCC-TFE3 regulates migration and invasion of translocation renal cell carcinomas via activation of Drp1-dependent mitochondrial fission.
Wang B; Gan W; Han X; Li D
Cell Biol Int; 2020 Aug; 44(8):1727-1733. PubMed ID: 32339358
[TBL] [Abstract][Full Text] [Related]
36. A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
Qu Y; Feng J; Wu X; Bai L; Xu W; Zhu L; Liu Y; Xu F; Zhang X; Yang G; Lv J; Chen X; Shi GH; Wang HK; Cao DL; Xiang H; Li L; Tan S; Gan HL; Sun MH; Qiu J; Zhang H; Zhao JY; Ye D; Ding C
Nat Commun; 2022 Apr; 13(1):2052. PubMed ID: 35440542
[TBL] [Abstract][Full Text] [Related]
37. TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis.
Lee HJ; Shin DH; Kim SY; Hwang CS; Lee JH; Park WY; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
Histopathology; 2018 Nov; 73(5):758-766. PubMed ID: 29968390
[TBL] [Abstract][Full Text] [Related]
38. Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Wang Z; Liu N; Gan W; Li X; Zhang G; Li D; Guo H
J Int Med Res; 2017 Aug; 45(4):1287-1296. PubMed ID: 28587544
[TBL] [Abstract][Full Text] [Related]
39. Melanotic MiT family translocation neoplasms: Expanding the clinical and molecular spectrum of this unique entity of tumors.
Saleeb RM; Srigley JR; Sweet J; Doucet C; Royal V; Chen YB; Brimo F; Evans A
Pathol Res Pract; 2017 Nov; 213(11):1412-1418. PubMed ID: 28969862
[TBL] [Abstract][Full Text] [Related]
40. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
